Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Lowers Price Target to $115
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity has maintained a Hold rating on Zimmer Biomet Holdings but lowered the price target from $120 to $115.
September 10, 2024 | 3:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Canaccord Genuity has maintained a Hold rating on Zimmer Biomet Holdings and reduced the price target from $120 to $115, indicating a slightly less optimistic outlook.
The reduction in price target from $120 to $115 by Canaccord Genuity suggests a less optimistic view on Zimmer Biomet's short-term performance, which could lead to a negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100